If referencing Kenny, he does have an adequate salary.
In the real biotech world a company may announce in Jan it's taking a new drug into pre-clinical soon, and expects to be in clinical by Q3. Then it happens. Q3 comes, and a CT starts. In the intervening time, no garbage about tests, manufacturing QC, and manuals included in countless PR pumps. It seems the "crystal ball" works well for real biotech companies 6-9 months out into the future.
Meanwhile back in the Microcrap Kenny world, after 6-8 yrs, he claims the filing is "planned" to be ready for submission in the "coming week" (e.g. this week). Yet he is unable to say an IND WILL be submitted next week. So close, yet he can't give a target week? Ooooh... that's right there's that super complicated Patient Consent form to work on.
News 
Market Data 
Discover 
